Biosystems International Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 7
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 3

Biosystems International General Information

Description

Operator of an in-vitro diagnostics research and development platform designed to discover and develop disease-specific plasma protein epitope panels. The company focuses on the development of diagnostic tests in the areas of cancer and metabolic diseases, and commercialization of antibody arrays for plasma profiling by unique monoclonal antibody libraries, generated against natural epitopes of the normal and disease plasma proteomes, via normalized, limited, or shotgun immunization, enabling pharmaceutical companies and medical professionals to detect early stages of various cancers and chronic diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Discovery Tools (Healthcare)
Parent Company
Primary Office
  • Nagyerdei Krt. 98.
  • Debrecen, 4032
  • Hungary
+36 (06 00) 000 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biosystems International Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Secondary Transaction - Private 00.000 Completed Generating Revenue
7. Grant 02-Aug-2016 000.00 00.000 Completed Generating Revenue
6. Later Stage VC 01-Jan-2011 00.000 Completed Generating Revenue
5. Early Stage VC 19-Jul-2010 00.000 00.000 Completed Generating Revenue
4. Early Stage VC 29-Oct-2008 00.000 00.000 Completed Startup
3. Merger/Acquisition 16-Jan-2008 00.000 Completed Startup
2. Grant 30-May-2007 $3.92M $3.95M Completed Startup
1. Seed Round 01-Apr-2005 $3.95M $3.95M Completed Startup
To view Biosystems International’s complete valuation and funding history, request access »

Biosystems International Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of an in-vitro diagnostics research and development platform designed to discover and develop disease-specific
Laboratory Services (Healthcare)
Debrecen, Hungary
7 As of 2021
00.000
000000 - 000 00.000

000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitati
000000000 00000 (0000000000)
Martinsried, Germany
00 As of 0000
000000&0

00000000

lamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vol
0000000000000
Lund, Sweden
00 As of 0000
0000000000 0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biosystems International Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Crelux Corporate Backed or Acquired Martinsried, Germany 00 000000&0
00000000 000000000 Venture Capital-Backed Lund, Sweden 00 0000000000 0
0000000 Venture Capital-Backed Strasbourg, France 000 00.000 000000000000 00.000
000000000 00000000 Formerly PE-Backed Bedford, MA 00 000.00 000000&0 000.00
To view Biosystems International’s complete competitors history, request access »

Biosystems International Executive Team (8)

Name Title Board Seat Contact Info
Andrea Hollai Chief Financial Officer
Andras Guttman Ph.D Co-Founder & Chief Technology Officer
Barry Karger Ph.D Co-Founder & Scientific Advisory Board Member
Hubertus Sulkowski General Counsel
You’re viewing 4 of 8 executive team members. Get the full list »

Biosystems International Board Members (3)

Name Representing Role Since
Barry Karger Ph.D Biosystems International Co-Founder & Scientific Advisory Board Member 000 0000
Laszlo Fesus Ph.D Biosystems International Scientific Advisory Board 000 0000
Peter Zavodsky Ph.D Biosystems International Scientific Advisory Board Member 000 0000
To view Biosystems International’s complete board members history, request access »

Biosystems International Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biosystems International Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Euroventures Venture Capital Minority 000 0000 000000 0
To view Biosystems International’s complete investors history, request access »

Biosystems International Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000000 13-Sep-2010 0000000000 Biotechnology 000000 00000 00.0
To view Biosystems International’s complete investments history, request access »